COX2 catalyzes the production of eicosanoids that enhance GBM angiogenesis, growth, immune evasion, and suppression downstream via the synthesis of vascular endothelial growth factor (VEGF) [125,127]. The gene discussed is VEGFA; the disease is glioblastoma.